A Study on the Intervention Effect of Recollection Therapy on Depression in Elderly Patients with Chronic Diseases

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2600121004

Enrollment

Unknown

Registered

2026-03-24

Start date

2026-03-31

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Diseases with Depressive Symptoms in the Elderly

Interventions

Reminiscence Therapy Group:Guided recall of past experiences (e.g., childhood, work, marriage, etc.), approximately 25 minutes per session

Daily Conversation Control Group:General daily communication (e.g., diet, ward life, etc.), without systematic reminiscence

Life Experiences Group:Focus on daily life and familiar situations (e.g., family gatherings, favorite music, etc.)

Peak Experiences Group:Focus on life highlights or personal achievements (e.g., travel, career accomplishments, etc.)

Eligibility

Sex/Gender

All

Age

60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age: Aged 60-85 years, regardless of gender. 2. Disease Characteristics: Diagnosed with at least one chronic disease (e.g., hypertension, diabetes, coronary heart disease, chronic obstructive pulmonary disease, etc.) with a relatively stable medical condition and no acute episodes. 3. Psychological Status: Screened for depression with a PHQ-9 score >= 5, indicating at least mild depressive symptoms. 4. Cognitive Ability: Alert, without severe cognitive impairment or aphasia, able to understand and complete the questionnaire content (MMSE >= 24). 5. Communication Ability: Able to communicate effectively in Mandarin, with essentially normal hearing and expression. 6. Informed Consent: Voluntary participation in the study with a signed written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Cognitive or Mental Disorders: Suffering from cognitive impairment or severe mental illness. 2. Unstable Medical Condition: Unstable medical condition or presence of safety risks during the intervention period. 3. Concurrent Relevant Treatment: Currently receiving systematic psychotherapy or antidepressant medication. 4. Poor Compliance: Unwilling or unable to complete the entire study procedure.

Design outcomes

Primary

Measure	Time frame
Depressive Symptoms;	—

Secondary

Measure	Time frame
Self-Continuity;Self-Identity;Psychological Well-being;	—

Countries

China

Contacts

Public ContactXiaofeng Xie

West China Hospital of Sichuan University

xiaofeng_xie@scu.edu.cn+86 153 9761 1001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026